BetterLife Pharma Inc.
BetterLife Pharma Inc.
BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.
BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder and other neuro-psychiatric and neurological disorders.
BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency.
BetterLife also owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development.
BetterLife Pharma Inc. (BETR)
BetterLife Pharma Inc. (BETR)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| TD Securities Inc. | 2,000 | 0.085 | 0.09 | 20,000 | Anonymous |
| TD Securities Inc. | 1,000 | 0.085 | 0.09 | 25,000 | TD Securities Inc. |
| BMO Nesbitt Burns Inc. | 30,000 | 0.085 | 0.095 | 2,000 | Raymond James Ltd. |
| National Bank Financial Inc. | 1,000 | 0.08 | 0.10 | 25,000 | TD Securities Inc. |
| National Bank Financial Inc. | 25,000 | 0.08 | 0.10 | 18,000 | RBC Capital Markets |
| National Bank Financial Inc. | 1,000 | 0.08 | 0.11 | 25,000 | TD Securities Inc. |
| TD Securities Inc. | 20,000 | 0.075 | 0.115 | 1,000 | Raymond James Ltd. |
| BMO Nesbitt Burns Inc. | 20,000 | 0.07 | 0.12 | 50,000 | Anonymous |
| TD Securities Inc. | 50,000 | 0.05 | 0.13 | 25,000 | Anonymous |
| 0 | 0.00 | 0.13 | 1,000 | National Bank Financial Inc. |
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 3 | 33,000 | 0.085 | 0.09 | 45,000 | 2 |
| 3 | 27,000 | 0.08 | 0.095 | 2,000 | 1 |
| 1 | 20,000 | 0.075 | 0.10 | 43,000 | 2 |
| 1 | 20,000 | 0.07 | 0.11 | 25,000 | 1 |
| 1 | 50,000 | 0.05 | 0.115 | 1,000 | 1 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
|---|---|---|---|---|---|---|
| Apr 4, 16:34 | 0.085 | 0.00 | 1,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 4, 16:34 | 0.085 | 0.00 | 1,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 3, 17:08 | 0.085 | 0.00 | 4,000 | Aviso Financial Inc. | Scotia Capital Inc. | CSE |
| Apr 3, 17:08 | 0.085 | 0.00 | 21,000 | Aviso Financial Inc. | Scotia Capital Inc. | CSE |
| Apr 2, 13:55 | 0.08 | -0.005 | 49,000 | BMO Nesbitt Burns Inc. | Anonymous | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Communiqués de presse
BetterLife Pharma Appoints New Director
